Titre:
  • Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection
Auteur:Montaner, Julio; Yeni, Patrick; Clumeck, Nathan; Fätkenheuer, Gerd; Gatell, Jose; Hay, Phillip; Seminari, Elena; Peeters, Monika P.; Schöller-Gyüre, Monika; Simonts, Myriam; Woodfall, Brian
Informations sur la publication:Clinical infectious diseases, 47, 7, page (969-978)
Statut de publication:Publié, 2008-10
Sujet CREF:Sciences bio-médicales et agricoles
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1086/591705
info:scp/52449097524